Company Filing History:
2 out of 1,744 
1 out of 1 
1 out of 280 
Years Active: 2015-2016
Title: Innovations in Cancer Treatment: The Contributions of Yassamine Lazrek
Introduction
Yassamine Lazrek, a pioneering inventor based in Montpellier, France, has made significant strides in the field of cancer research through her innovative inventions. With a remarkable portfolio that includes two patents, she is recognized for her contributions to the development of targeted therapies against cancer.
Latest Patents
Yassamine Lazrek's most recent patents include groundbreaking work on antibodies against HER3. The first patent focuses on antibodies against HER3 and their applications in cancer treatment. This invention provides isolated anti-human-HER3 antibodies or fragments, particularly an isolated monoclonal antibody that binds specifically to the extracellular domain of HER-3. This antibody competes for binding to the human HER-3 domain with another antibody obtained from hybridoma deposited as CNCM-I-4486. These antibodies hold great promise for developing effective cancer treatments.
Career Highlights
Throughout her career, Yassamine has been associated with notable research institutions that emphasize innovation and medical research. She has worked with the Institut National De La Santé Et De La Recherche Médicale (INSERM) and the Centre Val D'Aurelle—Paul Lamarque. Her work in these institutions has been instrumental in advancing the understanding of cancer biology and developing novel therapeutic approaches.
Collaborations
Collaboration is a key component of innovation, and Yassamine has had the opportunity to work alongside esteemed colleagues such as Thierry Chardes and Andre Pelegrin. Their joint efforts have enriched her research and contributed to the successful outcomes of her projects.
Conclusion
Yassamine Lazrek's commitment to addressing critical challenges in cancer treatment through her inventions showcases her vital role in the scientific community. With her patents aimed at developing targeted therapies, Lazrek is paving the way for future advancements in cancer research, reinforcing the importance of innovation in medical science.